PTLA
Portola Pharmaceuticals, Inc.
PTLA
PTLA
Delisted
PTLA was delisted on the 1st of July, 2020.
180 hedge funds and large institutions have $1.86B invested in Portola Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 70 increasing their positions, 53 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
65% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 49
Holders
180
Holding in Top 10
3
Calls
$84.1M
Puts
$66M
Top Buyers
| 1 | +$98.4M | |
| 2 | +$24.9M | |
| 3 | +$24.9M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$14.4M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$12M |
Top Sellers
| 1 | -$73.2M | |
| 2 | -$28.6M | |
| 3 | -$26.3M | |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$21.6M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$20.6M |